Alleima AB (publ) (ALLEI)
Nasdaq Stockholm · Sweden · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 93.75 |
|---|---|
| 52-week range | 70.00 – 122.90 |
| Return, 1 month / 3 months | −21.2% / −16.6% |
| Return, 1 year / 3 years | +17.0% / +54.0% |
| Trend | Below its 200-day average |
| RSI (14) | 21 |
| Volatility (1 year) | 35.9% |
| Worst drawdown (1 year) | -23.4% |
| Average daily value traded | 24.82M SEK |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alleima is a Swedish maker of advanced stainless steels and special alloys, based in Sandviken. It produces seamless tubes, precision strip steel, wire and medical wire, along with heating technology products such as resistance wires and elements. Its customers come from energy, chemical processing, aerospace, medical technology and other industrial sectors that need corrosion-resistant and high-temperature materials. The company supplies both standard and customised components for demanding engineering applications.
Alleima AB (publ) trades under the code ALLEI on the Nasdaq Stockholm in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alleima AB (publ) (ALLEI) trades on the Nasdaq Stockholm in Sweden. It last closed at SEK 93.75 on 27 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 194 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.0% and over the last three months it fell 16.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Stockholm
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -0.8% | ||
| From 52-week high | -23.4% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -16.6% | ||
| 6-month return | 18.8% | ||
| 12-month return, skipping the last month | 48.3% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.4% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 24.82M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −18.6% |
|---|---|
| 1 month | −21.2% |
| 3 months | −16.6% |
| 6 months | +18.8% |
| 1 year | +17.0% |
| 3 years | +54.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 115.45 / 94.49 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.14 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Apr 2026 | SEK 2.5000 |
| 29 Apr 2025 | SEK 2.3000 |
| 3 May 2024 | SEK 2.0000 |
| 3 May 2023 | SEK 1.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Stockholm; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.